The Scholarly Presentation

I have been in the scientific arena since 1972, 30 long years. By my rough estimate, I have attended an average of four seminars a week, for a total of over 5,000 seminars. I have lost count of the meeting presentations. However, with my tongue firmly planted in my cheek, I'm offering here some random thoughts about the scientific talks I have heard over the years.   At a meeting, graduate students often stick to the time limit; Principal Investigators usually go over. I think that the r

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

I think that the reason for this is quite simple. Poor graduate students are often so excited about going to a meeting that they get their slides ready before the meeting and actually rehearse, often compulsively, before their peers, their mentors, and before their long suffering moms and siblings. They cut and prune their text to make sure that the talk ends within the allotted 12 minutes, and that there is time for questions. If you add to this the fact that they are often nervous and talk faster than they have done in the conference rooms of their home departments, they always end well before the bell goes off.

Most P.I.s seem to harbor the unjustified conviction that they can give any talk, anywhere extemporaneously. They always misplace a critical slide, and tell you that they left it in the airport in Zurich (just so you know that they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Tv Rajan

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo